Home | Welcome to Contract Pharma   
Last Updated Friday, May 29 2015



A cell line resulting form the fusion of a continuously dividing cancer cell with a normal blood cell secreting a specific antibody to produce an immortal hybridoma cell line manufacturing a specific antibody or monoclonal antibody.

blog comments powered by Disqus

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On